Disease/Infection News

RSS

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.

3 May 2023

Study examines the reinfection of SARS-CoV-2 variants in children

Researchers characterized the children with severe acute respiratory syndrome coronavirus 2 reinfection.

3 May 2023

Key to preventing runaway inflammation in patients with severe COVID-19

A treatment to prevent runaway inflammation in patients with severe COVID-19 is a step closer after a University of Queensland-led study into how immune cells respond to the virus.

3 May 2023

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

Study reports on the effectiveness of monovalent mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death. In other words, the study looks at how well the mRNA vaccine works in preventing severe illness and death from COVID-19.

2 May 2023

Novel way of synthesizing artemisinin could lead to cost-effective treatment for malaria

Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) have developed a method to synthesize the highly potent antimalarial drug artemisinin, which could lead to a more cost-effective treatment for malaria.

2 May 2023

Rising bovine brucellosis outbreaks in Israel threaten dairy farms, public health

Researchers analyze Brucella melitensis outbreaks that affected dairy farms in Israel from 2006 to 2021.

2 May 2023

New insight into how the occludin protein mediates cell-to-cell transmission of SARS-CoV-2 virus

While the coronavirus continues to infect people around the world, researchers at the University of Missouri have identified a specific protein inside the human body that plays a critical role in how the virus spreads from cell to cell after infection -; a discovery that will help better understand the COVID-19 disease and could lead to the development of new antiviral drugs in the future.

2 May 2023

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Researchers tested the seroprevalence against SARS-CoV-2 in pet cats in the U.K.

2 May 2023

Study links commuting choices to heart health: Walk or cycle to impact cardiovascular risk

Study analyzed the relationship between commuting modes and distance with cardiovascular disease-related biomarkers using UK Biobank data. The results suggest that active commuting modes (cycling, walking) may be positively associated with select CVD biomarkers, while long-distance commuting by car is negatively associated.

1 May 2023

Virologist investigates Huanan seafood market's SARS-CoV-2 origins: Unexpected genetic connections revealed

Researcher analyzes the genetic material from environmental samples collected from the Huanan Seafood Market after it was closed on January 1, 2020, to investigate the role of the market in the early SARS-CoV-2 outbreak.

1 May 2023

Study identifies immune signature to predict severe COVID-19 in cardiovascular patients

Research investigates whether the severity of SARS-CoV-2 infection can be predicted by analyzing the immunophenotype in the blood of cardiovascular disease (CVD) patients.

1 May 2023

What are the benefits of exercise on cardiovascular health?

Researchers estimated the impact of exercise on cardiovascular (CV) health.

1 May 2023

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

Researchers conducted a retrospective analysis of seroprotection against tetanus and diphtheria among residents in Austria.

1 May 2023

The serious infectious threat response initiative service was essential for the efficient management of COVID-19

Researchers described the serious infectious threat response initiative (SITRI) service.

1 May 2023

Opening doors for broader participation in oral microbiome studies: the stability and comparability of ethanol-free mouthwash

Researchers compared the use of ethanol-free and ethanol-containing mouthwash for oral microbiome studies.

1 May 2023

Disease/Infection News

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

Study examines the reinfection of SARS-CoV-2 variants in children

Key to preventing runaway inflammation in patients with severe COVID-19

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

Novel way of synthesizing artemisinin could lead to cost-effective treatment for malaria

Rising bovine brucellosis outbreaks in Israel threaten dairy farms, public health

New insight into how the occludin protein mediates cell-to-cell transmission of SARS-CoV-2 virus

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Study links commuting choices to heart health: Walk or cycle to impact cardiovascular risk

Virologist investigates Huanan seafood market's SARS-CoV-2 origins: Unexpected genetic connections revealed

Study identifies immune signature to predict severe COVID-19 in cardiovascular patients

What are the benefits of exercise on cardiovascular health?

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

The serious infectious threat response initiative service was essential for the efficient management of COVID-19

Opening doors for broader participation in oral microbiome studies: the stability and comparability of ethanol-free mouthwash

Reducing COVID-19 burden: could Bacille Calmette-Guérin (BCG) vaccines confer protection?

AHA ranks popular US diets for cardiovascular fitness

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

Addressing the much-needed development of effective pneumococcal vaccination policies for long-term care settings

Tracking SARS-CoV-2 Omicron variant XBB1.16

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News